Literature DB >> 11278607

The tumor-sensitive calmodulin-like protein is a specific light chain of human unconventional myosin X.

M S Rogers1, E E Strehler.   

Abstract

Human calmodulin-like protein (CLP) is an epithelial-specific Ca(2+)-binding protein whose expression is strongly down-regulated in cancers. Like calmodulin, CLP is thought to regulate cellular processes via Ca(2+)-dependent interactions with specific target proteins. Using gel overlays, we identified a approximately 210-kDa protein binding specifically and in a Ca(2+)-dependent manner to CLP, but not to calmodulin. Yeast two-hybrid screening yielded a CLP-interacting clone encoding the three light chain binding IQ motifs of human "unconventional" myosin X. Pull-down experiments showed CLP binding to the IQ domain to be direct and Ca(2+)-dependent. CLP interacted strongly with IQ motif 3 (K(d) approximately 0.5 nm) as determined by surface plasmon resonance. Epitope-tagged myosin X was localized preferentially at the cell periphery in MCF-7 cells, and CLP colocalized with myosin X in these cells. Myosin X was able to coprecipitate CLP and, to a lesser extent, calmodulin from transfected COS-1 cells, indicating that CLP is a specific light chain of myosin X in vivo. Because unconventional myosins participate in cellular processes ranging from membrane trafficking to signaling and cell motility, myosin X is an attractive CLP target. Altered myosin X regulation in (tumor) cells lacking CLP may have as yet unknown consequences for cell growth and differentiation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11278607     DOI: 10.1074/jbc.M010056200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  26 in total

1.  Emanuel Strehler's work on calcium pumps and calcium signaling.

Authors:  Emanuel E Strehler
Journal:  World J Biol Chem       Date:  2011-04-26

2.  Gain-of-Function Mutations in KCNN3 Encoding the Small-Conductance Ca2+-Activated K+ Channel SK3 Cause Zimmermann-Laband Syndrome.

Authors:  Christiane K Bauer; Pauline E Schneeberger; Fanny Kortüm; Janine Altmüller; Fernando Santos-Simarro; Laura Baker; Jennifer Keller-Ramey; Susan M White; Philippe M Campeau; Karen W Gripp; Kerstin Kutsche
Journal:  Am J Hum Genet       Date:  2019-05-30       Impact factor: 11.025

3.  Myosin-X is a molecular motor that functions in filopodia formation.

Authors:  Aparna B Bohil; Brian W Robertson; Richard E Cheney
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-07       Impact factor: 11.205

4.  Kinetic analysis reveals differences in the binding mechanism of calmodulin and calmodulin-like protein to the IQ motifs of myosin-10.

Authors:  Ariel J Caride; Richard D Bennett; Emanuel E Strehler
Journal:  Biochemistry       Date:  2010-09-21       Impact factor: 3.162

Review 5.  Myosin-X: a MyTH-FERM myosin at the tips of filopodia.

Authors:  Michael L Kerber; Richard E Cheney
Journal:  J Cell Sci       Date:  2011-11-15       Impact factor: 5.285

6.  CIB1 and CaBP1 bind to the myo1c regulatory domain.

Authors:  Nanyun Tang; Tianming Lin; Jun Yang; J Kevin Foskett; E Michael Ostap
Journal:  J Muscle Res Cell Motil       Date:  2007-11-10       Impact factor: 2.698

7.  The novel murine Ca2+-binding protein, Scarf, is differentially expressed during epidermal differentiation.

Authors:  Meeyul Hwang; Maria I Morasso
Journal:  J Biol Chem       Date:  2003-09-11       Impact factor: 5.157

Review 8.  Non-muscle myosins in tumor progression, cancer cell invasion, and metastasis.

Authors:  Jessica L Ouderkirk; Mira Krendel
Journal:  Cytoskeleton (Hoboken)       Date:  2014-08-18

9.  A novel form of motility in filopodia revealed by imaging myosin-X at the single-molecule level.

Authors:  Michael L Kerber; Damon T Jacobs; Luke Campagnola; Brian D Dunn; Taofei Yin; Aurea D Sousa; Omar A Quintero; Richard E Cheney
Journal:  Curr Biol       Date:  2009-04-23       Impact factor: 10.834

10.  Isolation and characterization of the primary epithelial breast cancer cells and the adjacent normal epithelial cells from Iranian women's breast cancer tumors.

Authors:  Nassim Faridi; S Zahra Bathaie; Saeid Abroun; Parvaneh Farzaneh; Hamid Karbasian; Fuyuhiko Tamanoi; Mohammad-Ali Mohagheghi
Journal:  Cytotechnology       Date:  2018-01-29       Impact factor: 2.058

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.